Berlin Heals Holding AG is a Swiss MedTech company founded in 2014, specializing in innovative treatments for heart failure. The company has developed the C-MIC (Cardiac Microcurrent) system, an implantable device designed to reverse heart failure by delivering constant direct microcurrent to the heart, reducing inflammation and promoting cardiac remodeling. This device is under regulatory evaluation and has received Breakthrough Device Designation from the FDA. Berlin Heals aims to provide less invasive treatment options through outpatient cardiac procedures, potentially improving recovery times and accessibility for patients worldwide.
Berlin Heals Holding AG had 40 employees as of November 2, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Berlin Heals Holding AG had 3,248 followers as of November 2, 2026. The number of followers increased by 12 (0.37%) week-over-week.
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Sep 01, 2025 | Investment | $5.00M | ― |
| Sep 01, 2025 | Series A | $5.00M | ― |
| Feb 18, 2025 | Investment | $7.00M | ― |
A snapshot of private companies similar to Berlin Heals Holding AG, helping you discover and navigate related company profiles.

